Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID: EEG-guided remimazolam vs propofol TIVA for perioperative neurocognitive disorders
ChiCTR2300078307Phase 4Recruiting
- Sponsor
- Army Medical University
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in perioperative neurocognitive disorder and postoperative delirium (POD) comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Postoperative delirium. Started Sep 2023; status: recruiting.
02
Drugs
remimazolampropofol
03
Conditions
perioperative neurocognitive disorderpostoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2300078307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078307.